Schmid is the executive director of the HIV+Hepatitis Policy Institute.
A Win for Coverage, but Can People Still Access HIV Prevention?
Carl Schmid on the US Supreme Court ruling, proposed Centers for Disease Control and Prevention cuts, stigma, and why equitable PrEP access, including new long-acting options, depends on more than insurance.
Read More
Carl Schmid on Supreme Court Ruling Upholding ACA Preventive Coverage and Its Impact on HIV Prevention
HIV+Hepatitis Policy Institute director discusses PrEP access, insurer compliance, and challenges ahead following the landmark decision.
With Federal Offices Related to Fighting Infectious Disease Closing, Who Will Pick Up the Slack?
Carl Schmid, executive director, HIV+Hepatitis Policy Institute, speaks to these closings.
The Business Sector's Advocacy to Maintain Funding for HIV Prevention, Research, Treatment
A coalition of employers, the US Business Action to End HIV, sent a letter to Congress outlining the continued need for support from the federal government.